Ennov to Offer “Work from Home” Collaboration Solution for Companies Impacted by COVID-19
selects the Ennov platform
for Regulatory Information Management
Top 25 Pharmaceutical Company Selects Ennov for Global Regulatory Information Management
Ennov recognized by Gartner in 2018 Market Guide for Quality Management System Software
Ennov is Recognized in Gens & Associates 2018 World Class RIM Study
Ennov recognized in Gartner's Hype Cycle for Life Sciences
An intuitive and unified content and information management platform to support and enrich the entire Life Sciences product life cycle
Download Septodont's Case Study
For more than 19 years, Ennov has been developing innovative, powerful and easy-to-use software for document and process management.
Using the knowledge and best practices gained from more than 150 Life Sciences customers and over 500 total customers, Ennov has designed and built solutions specifically for the health and life sciences sectors: Quality, Pharmacovigilance, Clinical Operations and Regulatory Affairs.
Ennov Compliance Platform
Unified Document Management, Business Process Management, Business Intelligence and Learning Management
Ennov solutions are built on our Unified Compliance Platform which is designed specifically for the management of regulated content and processes.
The Ennov platform is the technological foundation of our Regulatory (EDMS, Dossier Publishing, RIM, IDMP), Quality (EDMS, QMS) and Clinical (eTMF and CTMS) solutions.
Our platform approach provides significant advantages over other products on the market:
What's happening at Ennov
Ennov are pleased to announce that the Danish pharmaceutical company Pharmacosmos has implemented Ennov Doc and Ennov Training for the management of their global Quality and GxP documentation. Following the installation, configuration and validation of the software, the system was
Ennov is pleased to announce the addition of Steve Clark to our team of Regulatory experts. Steve has over 20 years of global Regulatory operations experience that he gained at leading life sciences companies such as Amgen, Merck, Gilead and
Synairgen has selected Ennov PV to support the conduct of a clinical trial of SNG001 in patients with COVID-19. Synairgen will be using the Ennov PV Works solution to collect, manage and report clinical safety data associated with the trial.